Back
Protagonist Therapeutics Vs. Tandem Diabetes Care Industry Stock Comparison
Buy
65
PTGX
Protagonist Therapeutics
Last Price:
30.44
Seasonality Move:
18.27%
Buy
72
TNDM
Tandem Diabetes Care
Last Price:
51.76
Seasonality Move:
17.33%
Buy
65
Protagonist Therapeutics (PTGX)
is a Buy
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $30.54. The Score for PTGX is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- PTGX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
72
Tandem Diabetes Care (TNDM)
is a Buy
Is Tandem Diabetes Care a Buy, Sell or Hold?
- The current Tandem Diabetes Care [TNDM] share price is $49.68. The Score for TNDM is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- TNDM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $30.54
The current trend is moderately bullish and PTGX is experiencing selling pressure, which indicates risk of future bearish movement.
TNDM Stock Price Chart
What is Tandem Diabetes Care's stock price today?
-
The Tandem Diabetes Care share price today is $49.68
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TNDM is experiencing slight selling pressure.
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.23 | Buy |
| Relative Strength Index (14 RSI): | 60.31 | Buy |
| Chaikin Money Flow: | -298466 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.35 - 30.35) | Buy |
| Bollinger Bands (100): | (25.04 - 29.74) | Buy |
TNDM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.93 | Buy |
| Relative Strength Index (14 RSI): | 71.43 | Buy |
| Chaikin Money Flow: | -744323 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.66 - 47.5) | Buy |
| Bollinger Bands (100): | (23.98 - 38.82) | Buy |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.12 | Sell |
| 20-day SMA: | 28.34 | Buy |
| 50-day SMA: | 27.85 | Buy |
| 200-day SMA: | 22.66 | Buy |
| 8-day EMA: | 30.68 | Sell |
| 20-day EMA: | 29.24 | Buy |
| 50-day EMA: | 28.1 | Buy |
| 200-day EMA: | 24.4 | Buy |
TNDM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.91 | Buy |
| 20-day SMA: | 43.58 | Buy |
| 50-day SMA: | 37.07 | Buy |
| 200-day SMA: | 26.92 | Buy |
| 8-day EMA: | 48 | Buy |
| 20-day EMA: | 44.18 | Buy |
| 50-day EMA: | 38.44 | Buy |
| 200-day EMA: | 31.68 | Buy |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $2.69 per share, an increase this year of $3.70 per share, and a decrease next year of $1.31 per share.
Tandem Diabetes Care Earnings Growth & TNDM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.15 per share, and an increase next year of $0.54 per share.
Protagonist Therapeutics Technical Analysis
| May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | May 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 10 | 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Tandem Diabetes Care Technical Analysis
| May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | May 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 10 | 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||